Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A 2 inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines

By Binisti C.   Assogba L.   Touboul E.   Mounier C.   Huet J.   Ombetta J.-E.   Dong C.Z.   Redeuilh C.   Heymans F.   Godfroid J.-J.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 10, 2001-10 ,pp. : 809-828

Elsevier

Access to resources Recommend Favorite

Platelet-Activating Factor (PAF) Antagonists Attenuate Inflammatory- Based Pain: Potential Cellular and Anatomical Sites of PAF Action

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 2, 2006-01 ,pp. : 129-133

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H.   Magoc T.J.   Tapang P.   Luo G.   Morgan D.W.   Curtin M.   Sheppard G.S.   Xu L.   Heyman H.R.   Davidsen S.K.   Summers J.B.   Carter G.W.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation

By Lee L.-W.   Peng H.-C.   Ko W.-C.   Hung W.-C.   Su C.-H.   Lin C.-H.   Huang T.-F.   Yen M.-H.   Sheu J.-R.  

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 239-246

Elsevier

Access to resources Recommend Favorite

Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat

By Yoshikawa D.   Shiga T.   Saito S.   Morita T.   Imai T.   Goto F.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 241-245

Elsevier

Access to resources Recommend Favorite